Full-Time

Facilities Cleaning Program Lead

Posted on 4/1/2025

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Compensation Overview

$93.5k - $128.5k/yr

Mid, Senior

Bridgewater Township, NJ, USA

Category
Generalist Operations
Quality Control & Compliance
Operations & Logistics
Requirements
  • High school diploma or GED required.
  • Associate’s degree from a two-year college or technical school preferred.
  • A minimum of 3-5 years related experience in GMP facilities. Good understanding of facility cleanings per agency guidance. Working in a Pharmaceutical / GMP facility experience preferred
  • An ability to build strong partnerships with internal customers and effectively integrate with external vendors to drive facility cleaning operations.
  • Ability to work independently and successfully, prioritize and manage multiple tasks simultaneously, integrate cross-functional issues and balance competing priorities effectively.
  • Ability to think critically, and demonstrated troubleshooting and problem-solving skills
  • Manage and work with vendors for routine equipment requirements and breakdowns.
  • cGMP manufacturing
  • Cleaning and facilities management
  • Proficient with Manufacturing Execution System (MES)
  • Quality Management knowledge, including Change control, Deviation, and CAPA’s.
  • EHS and regulatory standards (e.g. EPA, OSHA and DEA)
  • Bilingual preferred (English / Spanish).
Responsibilities
  • Lead the 3rd shift cleaning team to ensure facility readiness for manufacturing operations and quality control labs next shift.
  • Communicate with all key stakeholders (MFG, FAC, QC, etc..) any issues or concerns with facility cleanings.
  • Performs daily walkthroughs of the facility to ensure all proper daily, weekly or monthly cleanings are being executed per schedule
  • Enforce all departmental and organizational policies and procedures.
  • Ensures proper cleaning materials, parts and spare parts are identified and available for daily, weekly and monthly cleanings.
  • Ensure collaboration with key stakeholders and functions.
  • Supports the planning, coordination, preparation, and timely execution of cleaning for maintenance shutdowns.
  • Inspect and evaluate the physical appearance of the facility and coordinate with site management for any cleanings / repairs.
  • Report and address any unsafe conditions or environmental concerns.
  • Ability to interact with all levels within the organization.
Desired Qualifications
  • Associate’s degree from a two-year college or technical school preferred.
  • Bilingual preferred (English / Spanish).

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in personalized medicine, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. The company's goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Franklin Township, New Jersey

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's $150M investment in Belgium expands cell therapy production capabilities.
  • Alan Bash's appointment as President of CARVYKTI® strengthens leadership in the CAR-T market.
  • Collaboration with Multiply Labs could enhance efficiency in cell therapy manufacturing.

What critics are saying

  • Investigation into possible securities fraud could impact Legend Biotech's reputation.
  • Emergence of a new Carvykti rival threatens market share and revenue.
  • Rapid expansion may strain financial resources and operational focus.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective treatments.
  • Legend Biotech combines discovery, development, and commercialization in its business model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

1%

2 year growth

0%
PharmaData
Jun 4th, 2025
Legend Biotech Reports Landmark 5-Year CARVYKTI Data at ASCO 2025

Legend Biotech reports landmark 5-year CARVYKTI data at ASCO 2025.

Access News Wire
May 15th, 2025
LEGN ALERT: Levi & Korsinsky Investigates Legend Biotech Corporation for Possible Securities Fraud Violations

NEW YORK, NY / ACCESS Newswire / May 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Legend Biotech Corporation ("Legend Biotech Corporation") (NASDAQ:LEGN) concerning possible violations of federal securities laws.

Fierce Pharma
Mar 12th, 2025
J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms

J&J, Legend to invest $150M in Belgium cell therapy facility as new Carvykti rival looms.

The Yellow Brick Road
Mar 3rd, 2025
YB new stock pitches (Mon, Mar 3)

Legend Biotech Corporation (LEGN) is developing a promising CAR-T cancer drug in partnership with Johnson & Johnson.

ROI-NJ
Nov 5th, 2024
Legend Biotech Names Alan Bash As Leader Of Its Cer-T Product

Legend Biotech Corporation on Tuesday said it appointed Alan Bash as president of its CAR-T product CARVYKTI®. In this newly created role, Bash will be responsible for managing the continued growth of CARVYKTI®, overseeing the Somerset-based firm’s commercial, technical operations, and quality functions of the franchise.“This expansion in our leadership structure is on the heels of CARVYKTI’s recent successes, including recent approvals from the U.S. Food and Drug Administration and European Commission for label expansion,” Ying Huang, chief executive officer of Legend Biotech said. “Legend Biotech welcomes Alan and is confident that his wealth of operational knowledge in oncology will help further strengthen the Company’s leadership role in the treatment of multiple myeloma.”Previously, Bash served as chief executive officer for two oncology-focused biotech companies, most recently at ZielBio, and before that, as president and CEO at Checkmate Pharmaceuticals. He also had a 23-year career with Bristol Myers Squibb, where he held various leadership positions across all major therapeutic areas—including oncology—driving the U.S. launch of Opdivo® and the expansion of additional cancer treatments such as Yervoy® and Erbitux ®.Bash contributed to several blockbuster products in collaboration with other companies, including Abilify® with Otsuka and Eliquis® with Pfizer.“As the fastest launched CAR-T product on the market, CARVYKTI has already produced impressive momentum,” Bash said

INACTIVE